A wearable intelligent defibrillator monitoring device

Through the removable WCD loop belt and conductive fluid flow connection technology, the problem of electrode position fixation and long-term connectivity is solved, and the accuracy and adaptability of electrocardiogram detection and defibrillation treatment is achieved, suitable for different body types and heart rate arrhythmia types .

CN115349870BActive Publication Date: 2024-11-26XUANWU HOSPITAL OF CAPITAL UNIV OF MEDICAL SCI
View PDF 14 Cites 0 Cited by

Patent Information

Application Number
CN202210791262.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-04
Publication Date
2024-11-26
Estimated Expiration
2042-07-04

AI Technical Summary

Technical Problem

Existing wearable ECG monitoring devices cannot effectively define the electrodes at the target position of human skin, and the connection between the electrodes and the skin is not suitable for long-term use, so it cannot accurately identify and targetedly set up different types of heart rate arrhythmias.

Method used

The removable WCD loop belt and adjustment structure limit the electrocardiogram detection and defibrillation equipment to the patient's specific position, establish or end the electrical connection through the flow of conductive fluid between the inner and outer cavity, combining the chest and limb guidance. ECG testing was performed and various heart rate arrhythmias were adapted to different defibrillation electrodes and treatment modes.

Benefits of technology

It realizes stable connection and accurate position coverage of the electrodes, adapts to different body types and heart rate arrhythmia, improves the accuracy of electrocardiogram detection and the effect of defibrillation treatment, and is suitable for long-term use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115349870B_ABST
    Figure CN115349870B_ABST
Patent Text Reader

Abstract

The present invention relates to a wearable intelligent defibrillation monitoring device, comprising: a WCD ring belt, which is used to limit ECG detection and defibrillation equipment to a specific position of a patient, and is detachably connected to the patient in a manner that can cover an ECG monitoring area and a defibrillation area; an ECG module, which is used to obtain ECG data; a control module, which is used to analyze ECG module detection data and control the defibrillation module to perform defibrillation treatment; and a defibrillation module, which is used to provide cardioversion treatment and is provided with a plurality of defibrillation electrodes, wherein the defibrillation electrodes can establish or terminate electrical connection with the skin by a conductive liquid flowing back and forth between an inner cavity and an outer cavity. The defibrillation electrodes are limited to a target position on the patient's skin based on the structure of the WCD ring belt and the defibrillation electrodes, and are tightly connected and suitable for long-term use; and the control module is also provided with a plurality of cardioversion treatment strategies for different types of ECG states.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical device technology, in particular to the field of electrocardiogram monitoring and automatic defibrillation, and specifically to a wearable intelligent defibrillation monitoring device. Background Art

[0002] Cardiovascular and cerebrovascular diseases are one of the most important causes of death in modern times. Among them, cardiac fibrillation is a high-risk disease. If not treated in time, it may lead to sudden cardiac arrest (SCA) and endanger life. Cardiac fibrillation is divided into various arrhythmia diseases according to its location and characteristics, such as ventricular fibrillation, ventricular tachycardia, atrial fibrillation, atrial flutter, supraventricular tachycardia, etc.

[0003] Ventricular Flutter (VF), also known as ventricular fibrillation, is an extremely rapid and completely uncoordinated contraction of the ventricular muscle. The ventricle cannot contract mechanically and cannot complete the pump function. It can be caused by various cardiovascular diseases, such as myocarditis, coronary heart disease, cardiomyopathy, etc., arrhythmias caused by electrolyte disorders, electric shock, anesthesia and surgery and other unexpected factors. Some arrhythmia diseases may also cause ventricular fibrillation, such as frequent ventricular tachycardia and atrial fibrillation. The electrocardiogram shows: the QRS complex and T wave disappear, presenting a completely irregular wave-like curve with different shapes, frequencies and amplitudes.

[0004] Ventricular tachycardia (VT): abbreviated as VT, refers to a heart rhythm that originates from the ventricles, is spontaneous, and consists of 3 or more consecutive premature contractions with a frequency greater than 100 times / minute; the basis of ventricular tachycardia is ventricular premature beats. The electrocardiographic characteristic of ventricular premature beats is the appearance of wide and deformed QRS waves.

[0005] Atrial Fibrillation: Atrial fibrillation refers to an arrhythmia caused by the ectopic pacemaker in the atrium firing impulses at a frequency of more than 350 times. Atrial fibrillation is divided into paroxysmal atrial fibrillation, persistent atrial fibrillation and permanent atrial fibrillation; the cause of atrial fibrillation is due to ischemic heart disease, such as acute myocardial infarction, unstable angina and other diseases. For example, valvular heart disease is caused by mitral stenosis, mitral regurgitation, aortic stenosis, aortic regurgitation, etc., and it may also be primary atrial fibrillation. The electrocardiogram shows that the P wave disappears and is replaced by the f wave; the frequency of the f wave is 350 to 600 times / minute, and its size, shape and amplitude are different; the ventricular rhythm is absolutely irregular, usually 100 to 160 times / minute when not treated; the QRS complex morphology is normal, and when intraventricular differential conduction occurs, the QRS complex may be wide and deformed.

[0006] Atrial flutter is an intermediate type between atrial tachycardia and atrial fibrillation. The cause is that the frequency of the atrial ectopic pacemaker reaches 250 to 350 beats / minute and is regular, causing rapid and coordinated contraction of the atrium.

[0007] Supraventricular tachycardia (SVTA), also known as supraventricular tachycardia, is characterized by a series of rapid and regular QRS complexes on the electrocardiogram, with a frequency of 160 to 220 beats / minute and an average of about 200 beats / minute. Most QRS complexes are not widened or deformed, and maintain the shape of sinus rhythm. ST segment depression and T wave inversion are common; however, if accompanied by bundle branch block, intraventricular differential conduction or preexcitation syndrome, the QRS wave may be widened and deformed.

[0008] For the above-mentioned arrhythmia diseases, the cardiac defibrillator (electric cardioverter) is one of the rescue devices widely used in clinical practice. It is mainly composed of a control circuit, an electrocardiogram recorder, a power supply, and a defibrillator electrode plate. It uses pulse current to act on the heart and implement electric shock therapy, which can eliminate arrhythmia and restore the heart to sinus rhythm.

[0009] According to whether the electric shock pulse is synchronized with the R wave, it can be divided into two types: asynchronous and synchronous defibrillators. Asynchronous defibrillators are not synchronized with the patient's own R wave during defibrillation, and can be used for ventricular fibrillation or flutter. Synchronous defibrillators are synchronized with the patient's own R wave during defibrillation. It uses the human electrocardiogram signal R wave to control the release of current pulses, so that the electric shock pulse falls on the descending branch of the R wave instead of the irritable period, thereby avoiding the occurrence of ventricular fibrillation. It is mainly used for all rapid arrhythmias except ventricular fibrillation and flutter, such as supraventricular and ventricular tachycardia.

[0010] Among them, the electrical energy used for cardioversion is charged and discharged according to the electrical energy required for different types of arrhythmias: 250J~300J for ventricular fibrillation, which is asynchronous cardioversion; 150J~200J for ventricular tachycardia, 150J~200J for atrial fibrillation, 80J~100J for atrial flutter, and 100J for supraventricular tachycardia, all of which are synchronized cardioversion.

[0011] The working state of the heart is reflected by detecting the change in the potential difference (i.e., lead) between two specific points on the human body surface in the heart's electrical activity. ECG - The rhythmic contraction and relaxation of the heart is the power source for the blood to circulate in the blood vessels. The excitation and propagation of myocardial cells are based on the bioelectric activity of the cell membrane. The overall bioelectric activity of all myocardial cell membranes constitutes the ECG signal. ECG - ECG signals are transmitted to the body surface through human tissues. ECG electrodes are used on the body surface to monitor this signal and record it on the time axis to form an ECG.

[0012] Since the timing of electric shock pulse intervention for ventricular fibrillation and other arrhythmias is different, and different types of arrhythmias have different requirements for electric shock pulse energy, it is particularly important to quickly and accurately identify different types of arrhythmias. The arrangement of leads used for ECG detection and the connection between the leads and the patient play a key role in obtaining an accurate electrocardiogram.

[0013] In ECG testing, twelve-lead monitoring can more accurately and timely understand whether the patient has arrhythmia, as well as the type of arrhythmia, attack rate, occurrence time, duration and changes before and after drug treatment than the traditional single-lead monitoring system. It is very important for determining the nature of arrhythmia, selecting diagnostic and treatment methods, and observing treatment effects. In the clinical application of the twelve-lead monitoring system, when the patient's position changes or the electrodes have been used for a period of time, a lot of interference waves will appear on the screen, which will affect the judgment and analysis of the ECG. Therefore, it is of great significance to have a stable and effective electrical connection between the electrodes and the patient's skin.

[0014] In the prior art, according to the position of the electrode pads, they are divided into internal defibrillators and external defibrillators. Internal defibrillators place electrodes in the chest to directly contact the myocardium for defibrillation; external defibrillators place electrodes on the chest wall for indirect defibrillation. Among internal defibrillators, implantable cardioverter defibrillator (ICD) has been confirmed by many clinical studies to be an effective way to prevent sudden cardiac death (SCD); and wearable cardioverter defibrillator (WCD) among external defibrillators is suitable for a wider range of prevention and treatment because of its advantages such as simple and convenient wearing, rechargeable and reusable, and reliable defibrillation effect.

[0015] For example, the patent with publication number CN204815373U discloses a wearable intelligent defibrillator. The technical solution of this patent sets the ECG detection sensor on the wearable device so that the sensor is close to the heart, including subsequent signal processing and defibrillation control. This technical solution only relies on the wearable device to limit the sensor near the heart on the body surface. The sensor is not in close contact with the skin around the heart. The ECG measurement position is single, the measurement accuracy is not high, and the ECG cannot be analyzed in detail and accurately. The patent with publication number CN210541542U discloses a twelve-lead wearable ECG monitoring garment. The technical solution of this patent arranges the ECG detection sensor into twelve leads, which can effectively improve the diversity of measurement positions, but the connection between the sensor and the skin is still limited by the wearable device alone.

[0016] The patent with publication number CN113616927A discloses a system and method for remote ECG monitoring and health information management, which includes a WCD device, a cloud server, and a client; the WCD device is used to monitor the device's own operating information and the patient's ECG data in real time and send them to the cloud server; the cloud server is used to receive the device's own operating information and the patient's ECG data sent by the WCD device, establish a patient database, create, modify, and send corresponding medical information, alarm messages, etc. to the client; the client relies on a mobile terminal and / or PC to cooperate with the cloud server to provide services to the user. The WCD device monitors the patient's wear information and the patient's ECG information in real time.

[0017] The electrodes of the wearable cardioverter defibrillator, i.e., the WCD device, in the technical solution disclosed in the patent also rely on the pressure of the wearable vest, chest strap and waist belt to maintain close contact with the human body. The ECG electrodes are arranged in front of the patient, and the defibrillation electrodes are arranged in the front and back at the same time. The patent with the announcement number CN108289611B discloses a wearable device. The patented wearable external defibrillator may include a first defibrillator electrode pad and a second defibrillator electrode pad and a plurality of ECG sensing electrodes. The defibrillator electrode pad can be connected to the patient's skin through an adhesive and is electrically contacted based on a conductive material such as a conductive hydrogel or gel. The wearable defibrillator improves the contact between the skin and the device through the layered open hole structure and water vapor transport properties of the ECG electrodes and the defibrillation electrodes. The connection between the adhesive, gel and the skin is prone to detachment in the case of sweating or external interference. As time goes by, the bonding effect and conductive performance are significantly reduced, and it is not suitable for long-term wear. The patent with the announcement number CN108290035B discloses a conductive fluid reservoir that can be used to distribute conductive fluid to increase the electrical connection between the electrodes of the defibrillator and the patient. The container is provided with an inflatable and deflated air bag at the conductive fluid outlet to control the outflow of the conductive fluid. However, there is no connection between the deflated air bag and the opening. The conductive fluid in the container may leak from the opening due to shaking or external pressure, and the recovery of the conductive fluid flowing out of the opening is not involved. The conductive fluid may contaminate the electrodes and affect the normal functions of other components.

[0018] In summary, the connection method between the electrodes and the wearable device in the above scheme cannot effectively limit the electrodes to the target position on the human skin; the connection method between the electrodes and the skin also fails to take into account the difference in the functions of ECG electrodes and defibrillation electrodes, and does not provide a connection method that is tightly connected and suitable for long-term coverage; and there is no targeted setting for different types of arrhythmias in ECG detection and defibrillation treatment.

[0019] In addition, on the one hand, there are differences in understanding among those skilled in the art; on the other hand, the inventor studied a large number of documents and patents when making the present invention, but due to space limitations, not all details and contents are listed in detail. However, this does not mean that the present invention does not have the characteristics of these prior arts. On the contrary, the present invention already has all the characteristics of the prior art, and the applicant reserves the right to add relevant prior art to the background technology. Summary of the invention

[0020] In response to at least some of the shortcomings of the prior art, the present application provides a wearable intelligent defibrillator monitoring device, including: a WCD ring belt, which is used to limit ECG detection and defibrillator equipment to a specific position of the patient, and is detachably connected to the patient in a manner that can cover the ECG monitoring area and the defibrillation area; an ECG module, which is provided with limb leads and chest leads in a manner that can perform ECG detection on the patient's limbs and chest respectively; a defibrillator module, which is used to provide electrical cardioversion therapy and is arranged with a plurality of defibrillator electrodes in a manner that can be set to an anterior-posterior or anterior left defibrillation therapy mode; a control module, which is used to analyze the ECG module detection data and control the defibrillator module to perform defibrillation therapy; wherein the defibrillator electrodes can establish or terminate electrical connection with the patient's skin by allowing a conductive liquid to flow back and forth between the inner cavity and the outer cavity.

[0021] Patients with heart disease need long-term ECG monitoring, and for critically ill patients, timely interventional cardioversion therapy is required. In view of the problem that existing equipment cannot effectively limit the electrodes to the target area of ​​human skin, the WCD belt of the present application can adaptively cover the target area of ​​the patient based on the adjustable structure of the center belt, hand belt and leg belt. For example, the left adjustment part and the right adjustment part respectively arranged on both sides of the center belt can adjust the center belt horizontally, and the upper and lower adjustment parts can adjust the center belt vertically, so that the electrode arranged on the side of the center belt close to the patient's skin can accurately cover the chest target point; at the same time, the adjustable and detachable center belt can maintain good applicability for patients of different body shapes, and the connection is stable and effective.

[0022] Regarding the problem that the connection method between the electrodes and the skin does not take into account the difference in the functions of the ECG electrodes and the defibrillator electrodes, the ECG module and the defibrillator module of the present application, on the basis of cooperation, have different ways of establishing electrical connection with the patient. The ECG electrodes continuously maintain electrical connection with the patient's skin to detect ECG signals, while the defibrillator electrodes establish or end electrical connection with the patient's skin by allowing conductive fluid to flow back and forth between the inner cavity and the outer cavity. This can adapt to the conduction of higher energy and ensure comfort for long-term use.

[0023] In response to the problem that ECG detection and defibrillation treatment are not specifically set up for different types of arrhythmias, the ECG module of the present application is simultaneously provided with chest leads and limb leads. Compared with a single lead setting, the detection of ECG signals is more accurate and comprehensive; the several defibrillation electrodes of the defibrillation module can be configured into different defibrillation positions, and different defibrillation strategies of the control module can be used for cardioversion treatment. Compared with a single arrangement, different defibrillation positions and different defibrillation strategies can be combined to adapt to the cardioversion treatment plans for various heart rate diseases.

[0024] Preferably, the device includes a wearable WCD band, which is used to limit the ECG detection and defibrillation equipment to a specific position of the patient, and is detachably connected to the patient in a manner that can cover the ECG monitoring area and the defibrillation area, wherein the WCD band is provided with a chest band and a back band in a manner that respectively covers the chest area and the back area of ​​the patient at a certain height centered on the heart contour line through a central band provided on the upper body of the patient; the WCD band also includes leg bands and hand bands provided on the patient's legs and hands, respectively.

[0025] Preferably, the device includes an ECG module for ECG detection, and the ECG module is provided with limb leads and chest leads in a manner that ECG detection can be performed on the patient's limbs and chest respectively. The chest leads measure and monitor the patient's ECG data based on the chest electrodes arranged on the side of the chest cuff close to the patient's skin; the limb leads form an ECG detection system based on the limb electrodes arranged on the side of the leg cuff and the hand cuff close to the patient's skin to obtain more comprehensive and accurate ECG data. The limb electrodes and chest electrodes are detachably connected to the leg cuff / hand cuff and chest cuff through connecting stickers, so that the arrangement points of the electrodes can be adjusted as needed.

[0026] Preferably, the device includes a defibrillation module for performing defibrillation treatment on a patient, wherein the defibrillation module is provided with a first defibrillation electrode, a second defibrillation electrode and a third defibrillation electrode in a manner capable of forming different defibrillation treatment modes, wherein the first defibrillation electrode is limited to the heart area on the side of the chest band close to the patient's skin based on a chest band; the second defibrillation electrode is provided in a back area substantially at the same height as the heart and is limited by the back band; and the third defibrillation electrode is provided in a position substantially at the same height as the heart in the left armpit and is limited by the chest band.

[0027] Preferably, the central cuff arranged in the area at the same height as the patient's heart is provided with a left adjustment portion and a right adjustment portion at the position where the chest cuff and the back cuff are in contact, the left adjustment portion being arranged in the patient's left underarm area in a manner capable of laterally adjusting the chest cuff and the back cuff respectively; the right adjustment portion being arranged in the patient's right underarm area in a manner capable of laterally adjusting the chest cuff and the back cuff; so that the ECG module and the defibrillator module can adjust their positions in the chest cuff and the back cuff as needed, and the chest cuff and the back cuff are confined to an area at the same height as the patient's heart by means of laterally adjusting the left adjustment portion and the right adjustment portion.

[0028] Preferably, the center ring band also includes an upper and lower adjustment portion for adjusting the height of the center ring band on the patient's body, and the upper and lower adjustment portions are arranged with an upper adjustment strap and a lower adjustment strap in a manner that can respectively change the degree of contact tightness between the upper edge and the lower edge of the center ring band and the patient's body, so that the upper adjustment strap and the lower adjustment strap can change the enclosing dimensions of the upper edge and the lower edge of the center ring band based on the adjustment effect on the center ring band and cooperate with the left adjustment portion and the right adjustment portion to meet the tightening needs of the center ring band when moving up and down on the patient's body.

[0029] Preferably, at least one of the left adjustment portion, the right adjustment portion, the upper adjustment strap, the lower adjustment strap, the hand adjustment strap and the leg adjustment strap is provided with a positioning reference mark, and the positioning reference mark is arranged in a manner that can record the adjustment degree and position according to the set scale or regularly changing marks, so that the positioning reference mark can assist in the wearing and tightening of the WCD ring strap.

[0030] When the central loop is first arranged on the patient's body, the ECG module and the defibrillator module are not set first. The central loop is used to limit the chest loop and the back loop to positions that are basically consistent with the patient's heart height through the left and right adjustment parts, the upper and lower adjustment belts. When the central loop basically covers the position where the ECG module and the defibrillator module are arranged on the patient and the tightening force of the central loop on the patient's body is appropriate, positioning marks are set on the surface of the central loop to record the arrangement positions of the ECG electrodes and the defibrillator electrodes around the chest cavity, and the data of the positioning reference marks of the left adjustment part, the right adjustment part, the upper and lower adjustment belts are recorded; the central loop is untied, and the ECG electrodes and the defibrillator electrodes are arranged on the side of the central loop that contacts the patient's skin based on the positioning marks. The ECG electrodes and the defibrillator electrodes can be connected to the central loop based on the connection patch; the central loop with the ECG electrodes and the defibrillator electrodes arranged is reconnected to the patient, so that the arrangement positions of the ECG module and the defibrillator module in the central module are accurate and adjustable, and can also be adjusted to suit different patients.

[0031] Preferably, the leg cuff and the hand cuff for defining the limb electrodes are respectively provided with a leg adjustment strap and a hand adjustment strap in a manner that they can be stretched or contracted, so that the leg cuff and the hand cuff can change the encirclement size based on the leg adjustment strap and the hand adjustment strap, so that the leg cuff and the hand cuff can adapt to different limb positions of different sizes or limbs of different patients.

[0032] Preferably, when the device performs ECG detection and defibrillation treatment on a patient, the ECG module and the defibrillation module need to establish a reliable electrical connection with the patient's body. At least one of the first defibrillation electrode, the second defibrillation electrode, and the third defibrillation electrode includes an electrode shell for accommodating an electrode component and forming a protective shell, so that the electrode shell can resist external pressure and transmit pressure to an attachment ring in contact with the skin based on a shell-like structure with a cavity; the electrode shell is provided with a layered inner cavity and an outer cavity in the internal space in a manner that the conductive liquid can flow back and forth, wherein the inner cavity is arranged on the side of the outer cavity close to the patient's skin in a manner that the inner space of the inner cavity directly contacts the skin, and the outer cavity is connected to the inner cavity in a manner that it can accommodate the conductive liquid and discharge the conductive liquid into the inner cavity through at least one conductive liquid flow channel based on air pressure, for example, the volume of the outer cavity can be greater than the volume of the inner cavity, so that part of the conductive liquid in the outer cavity can fill the inner cavity.

[0033] In order to address the problem that the electrical connection between the electrode and the patient's skin is not firm and is not suitable for long-term use, the defibrillator electrode of the present application establishes a changeable electrical connection with the patient's skin based on a flowable conductive liquid. For example, when the ECG detection data remains normal for a long time, the defibrillator electrode can return the conductive liquid in the inner cavity to the outer cavity to avoid the discomfort caused by the conductive liquid infiltrating the patient's skin for a long time. When the ECG detection data is abnormal, the conductive liquid is transferred from the outer cavity to the inner cavity, so that the electrode sheet arranged in the inner cavity can re-establish an electrical connection with the patient's skin; and the defibrillator electrode can transfer the conductive liquid from the outer cavity to the inner cavity in advance based on the signal of the control module. Since the actual size of the inner cavity is small, the electrical connection is established when the ECG signal has not yet fully reached the point where defibrillation treatment is required, thereby avoiding the transfer of the conductive liquid and delaying the timing of electrical cardioversion treatment.

[0034] Preferably, when the first defibrillation electrode is limited to the patient's skin surface based on the effect of the central ring band, the electrode sheet of the first defibrillation electrode arranged in the inner cavity fits the patient's skin. An attachment ring for keeping the electrode shell in close contact with the skin is provided at the edge of the inner cavity and the skin contact surface, and the attachment ring is configured as a double-layer ring structure in such a way that the inner ring and the outer ring arranged at different radial distances from the center of the inner cavity can surround and form an internal hollow vacuum ring.

[0035] Preferably, a plurality of micropores through which attachment fluid can penetrate are arranged on the surfaces of the inner ring and the outer ring in contact with the skin, and the micropores are connected with the attachment fluid storage cavity based on the attachment fluid flow channel, so that the attachment fluid can be transported to the micropores by the capillary action of the attachment fluid flow channel and infiltrate the surfaces of the inner ring and the outer ring in contact with the skin, so that the inner ring and the outer ring can closely fit the skin based on the attachment fluid and form a vacuum ring isolated from the air, wherein, in the case where the vacuum ring forms an independent space based on the inner ring and the outer ring, the vacuum pump can configure the vacuum ring with a closed space having a certain vacuum degree by evacuating the inside of the vacuum ring, so that the electrode shell can be further attached to the patient's skin surface based on the pressure difference between the atmospheric pressure and the vacuum ring, and the combined action of the inner ring, the outer ring and the vacuum ring will also ensure the tightness of the inner cavity to the skin, so that the inner cavity can accommodate the conductive fluid without leakage.

[0036] Preferably, the attachment ring and vacuum ring made of materials with both flexibility and toughness can be well attached to the patient's skin surface, and can still maintain good adhesion even when the attachment part is uneven. Under the adhesion effect of the attachment ring and the vacuum ring on the skin, the gas pump applies gas to the outer cavity containing the conductive liquid through the outer cavity inflation valve and the outer cavity inflation channel, so that the conductive liquid is transferred to the inner cavity through the conductive liquid flow channel and the control valve under the action of gas extrusion and fills the inner cavity, and the air in the inner cavity is discharged from the inner cavity through the inner cavity inflation channel and the inner cavity inflation valve, so that the electrode sheet arranged in the inner cavity can establish an effective electrical connection with the skin based on the conductive liquid filling the inner cavity, wherein the control valve, the outer cavity inflation valve and the inner cavity inflation valve are opened / closed when the pressure difference on both sides is greater than / less than the pressure difference threshold, and the outer cavity inflation channel and the inner cavity inflation channel are respectively provided with at least one hydrophobic membrane at the connection between the outer cavity and the inner cavity, so that air can pass through but the conductive liquid cannot pass through.

[0037] Preferably, after the defibrillator module finishes the electric shock, the gas pump discharges air into the inner cavity through the inner cavity inflation channel and the inner cavity inflation valve, so that the conductive liquid in the inner cavity is discharged back to the outer cavity through the conductive liquid flow channel and the control valve under the pressure of the air, and the air in the outer cavity is discharged from the outer cavity through the outer cavity inflation channel and the outer cavity inflation valve, so that the defibrillator module keeps the conductive liquid in the outer cavity when not working to enhance the comfort of long-term wearing.

[0038] Preferably, the vacuum ring is provided with a first pressure sensor for obtaining the vacuum degree of the vacuum ring. When the vacuum degree detected by the first pressure sensor is less than the vacuum degree threshold, the vacuum pump starts automatically to reduce the pressure in the vacuum ring. The inner cavity and the outer cavity are provided with a second pressure sensor and a third pressure sensor. When the inflation pressure of the inner cavity or the outer cavity reaches the first pressure threshold, the gas pump stops working, and the pressure difference on both sides of the first inflation valve, the control valve and the second inflation valve gradually decreases to below the pressure difference threshold, and the first inflation valve, the control valve and the second inflation valve are closed.

[0039] Preferably, the way in which the ECG module establishes electrical connection with the skin can refer to the structure of the defibrillator module and simplify the setting. For example, at least one of the limb electrodes and the chest electrode is provided with an ECG electrode shell for accommodating the ECG electrode sheet, and a conductive liquid storage chamber for accommodating the conductive liquid is provided inside the ECG electrode shell, and the conductive liquid storage chamber transports the conductive liquid to the position where the ECG electrode sheet contacts the skin through the capillary action of the capillary pores connected to the conductive liquid storage chamber, so that the limb electrode / chest electrode that is in contact with the skin under the limitation of the leg band / hand band / center band establishes electrical connection with the skin.

[0040] The present application also provides a defibrillator electrode suitable for long-term use, the defibrillator electrode comprising an electrode shell for accommodating electrode components and forming a protective shell, so that the electrode shell capable of resisting external pressure transmits pressure to an attachment ring in contact with the skin of the electrode shell based on a shell-like structure with a cavity; the electrode shell is provided with a layered inner cavity and an outer cavity in the internal space in a manner that a conductive liquid can flow back and forth, wherein the inner cavity is arranged on a side of the outer cavity close to the patient's skin in a manner that the internal space of the inner cavity is in direct contact with the skin, and the outer cavity is connected to the inner cavity in a manner that the conductive liquid can be accommodated and discharged into the inner cavity through at least one conductive liquid flow channel based on air pressure, wherein an attachment ring for keeping the electrode shell in close contact with the skin is provided on the edge of the contact surface of the inner cavity with the skin, and the attachment ring is configured as a double-layer ring structure in a manner that an inner ring and an outer ring arranged at different radial distances from the center of the inner cavity can surround a vacuum ring with a hollow interior.

[0041] The present application also provides a monitoring method for a wearable intelligent defibrillator device, comprising one or more of the following steps: the control module establishes an electrical connection with the ECG module in a manner that can respectively obtain the detection data of the limb electrodes and the chest electrodes of the ECG module; the control module establishes an electrical connection with the defibrillator module in a manner that can send an electric shock signal to the defibrillator module according to the defibrillation strategy; the computing unit establishes an ECG of the patient based on the real-time detection data of the ECG module and the historical ECG data of the storage unit and determines the current ECG state including the first state to the eighth state based on the ECG characteristics, and the control module formulates a defibrillation strategy including at least the first strategy to the eighth strategy based on the first state to the eighth state; wherein, when the computing unit continuously obtains the current ECG data and the historical ECG data and performs continuous analysis, According to the different ECG states of the patient, different defibrillation strategies are respectively adopted to perform electric cardioversion treatment on the patient; the control module includes a positioning unit for determining the real-time position of the patient and an energy management unit for managing the electric energy required for defibrillation treatment, and the energy management unit can output electric shock signals of different energies to the defibrillation module according to different defibrillation strategies; the first defibrillation electrode and the second defibrillation electrode of the defibrillation module form an anterior-posterior position, and the first defibrillation electrode and the third defibrillation electrode form an anterior-left position. When the transition time of the ECG state from the first state to the third state to the seventh state is greater than or equal to the first time threshold, the defibrillation module preferentially adopts the anterior-posterior position for electric shock defibrillation; when the transition time from the first state to the third state to the seventh state is less than the first time threshold, the defibrillation module preferentially adopts the anterior-left position for electric shock defibrillation.

[0042] Preferably, the device includes a control module that analyzes detection data of the ECG module and controls the defibrillator module to perform defibrillation treatment, and the control module establishes an electrical connection with the ECG module in a manner that can respectively obtain detection data of the limb electrodes and chest electrodes of the ECG module; the control module establishes an electrical connection in a manner that can respectively send electric shock signals to the first defibrillator electrode, the second defibrillator electrode and the third defibrillator electrode of the defibrillator module according to the defibrillation strategy.

[0043] Preferably, the control module includes a storage unit for recording historical ECG data, and the storage unit is electrically connected to the computing unit, so that the computing unit can form an ECG based on the real-time detection data of the ECG module and the historical ECG data of the storage unit and send it to the storage unit for preservation. The storage unit and the computing unit are both electrically connected to the communication unit, so that the communication unit can transmit the data transmitted by the storage unit or the computing unit to the monitoring module based on wireless communication or wired means. The monitoring module includes at least one or more of a smart watch worn on the patient's hand, a monitoring terminal carried by a guardian, and a cloud server.

[0044] Preferably, the control module includes a positioning unit for determining the real-time position of the patient and an energy management unit for managing the electric energy required for defibrillation treatment. The energy management unit can output an electric shock signal of a certain energy to the defibrillation module according to different defibrillation strategies.

[0045] Preferably, the computing unit establishes an electrocardiogram of the patient based on the real-time detection data of the electrocardiogram module and the historical electrocardiogram data of the storage unit and determines the current electrocardiogram state including the first state to the eighth state based on the electrocardiogram characteristics, and the control module formulates a defibrillation strategy including at least the first strategy to the eighth strategy based on the first state to the eighth state; wherein the first state is a normal sinus rhythm state; the second state is a preparatory state with a slight deviation from sinus rhythm; the third state is a ventricular fibrillation state; the fourth state is a ventricular tachycardia state; the fifth state is an atrial fibrillation state; the sixth state is an atrial flutter state; the seventh state is a supraventricular tachycardia state; and the eighth state is a state in which sinus rhythm has not been fully restored after defibrillation treatment.

[0046] Preferably, when the computing unit continuously acquires current ECG data and historical ECG data and performs continuous analysis, different defibrillation strategies are respectively adopted to perform electrical cardioversion treatment on the patient according to different ECG states of the patient.

[0047] Preferably, there are two arrangements of the defibrillator module. The first is called the anterior-posterior position, that is, one defibrillator electrode pad is placed in the subscapular region of the back; the other defibrillator electrode pad is placed at the level of the 3rd to 4th intercostal space on the left edge of the sternum, which is suitable for energy saving, less potential complications, and selective cardioversion. The second is called the anterior-left position, in which the first defibrillator electrode pad is placed at the 2nd to 3rd intercostal space on the right edge of the sternum (the bottom of the heart), and the second defibrillator electrode is placed at the 5th intercostal space (the apex of the heart) in the left anterior axillary line, which is suitable for emergency electric shock defibrillation.

[0048] Preferably, the first defibrillation electrode and the second defibrillation electrode of the defibrillation module form an anterior-posterior position, and the first defibrillation electrode and the third defibrillation electrode form an anterior-left position. When the transition time of the ECG state from the first state to the third state to the seventh state is greater than or equal to a first time threshold, the defibrillation module preferentially adopts the anterior-posterior position for electric shock defibrillation; when the transition time from the first state to the third state to the seventh state is less than the first time threshold, the defibrillation module preferentially adopts the anterior-left position for electric shock defibrillation.

[0049] Preferably, when the calculation unit determines that the ECG state changes from the first state to the second state and the change time is greater than or equal to the second time threshold, the control module controls the defibrillator module to enter the pre-working state with the first power, the vacuum pump and the gas pump start to operate, and the conductive liquid enters the inner cavity, so that an electrical connection is established between the electrode sheet and the skin; when the calculation unit determines that the ECG state changes from the first state to the second state and the change time is less than the second time threshold, the control module controls the defibrillator module to enter the pre-working state with the second power, the vacuum pump and the gas pump start to operate, and the conductive liquid enters the inner cavity at an accelerated speed, so that a faster electrical connection is established between the electrode sheet and the skin.

[0050] Preferably, when the ECG state is in the eighth state, the control module controls the defibrillator module to maintain a pre-working state of establishing an electrical connection; when the time for the ECG state to recover from the second state to the eighth state to the first state is greater than a third time threshold, the control module controls the defibrillator module to discharge the conductive fluid in the inner cavity back to the outer cavity, and the defibrillator module ends the pre-working state.

[0051] Preferably, when the computing unit of the control module generates an electrocardiogram based on the current electrocardiogram data and the historical electrocardiogram and performs continuous analysis, the control module transmits the current electrocardiogram and the electrocardiogram to the cloud server of the monitoring module through the communication module for backup storage; when the computing module determines that the current electrocardiogram state is the third to seventh state, the control module simultaneously sends the current positioning data, electrocardiogram data, electrocardiogram, electrocardiogram state and defibrillation strategy information to the remote server, smart watch and monitoring terminal of the monitoring module, and the smart watch sends a warning signal to the patient in the form of vibration or light, reminding the patient to avoid exercise as much as possible or end exercise to maintain peace and stability; the monitoring terminal can remind the guardian or medical staff to pay attention to the patient's state and be ready to intervene to provide help.

[0052] Preferably, the smart watch and the monitoring terminal can call the remote server at any time to view the current ECG data, ECG and historical ECG data; when the calculation module determines that the time when the ECG state is in the third state to the seventh state is greater than the fourth time threshold, the control module sends an alarm signal to the smart watch and the monitoring terminal based on the communication unit and notifies medical staff to intervene. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] Figure 1 It is a simplified overall structural schematic diagram of a preferred embodiment of the present invention;

[0054] Figure 2 It is a simplified structural schematic diagram of the back side of a preferred embodiment of the present invention;

[0055] Figure 3 This is a schematic diagram of the central ring belt structure of a preferred embodiment of the present invention;

[0056] Figure 4 It is a schematic diagram of the leg and hand loop structures of a preferred embodiment of the present invention;

[0057] Figure 5 is a schematic diagram of the electrode structure of an electrocardiogram module in a preferred embodiment of the present invention;

[0058] Figure 6 is a schematic diagram of the electrode structure of a defibrillator module according to a preferred embodiment of the present invention;

[0059] Figure 7 It is a control connection schematic diagram of a preferred embodiment of the present invention.

[0060] Reference numerals list

[0061] 100: WCD belt; 101: center belt; 1011: left adjustment part; 1012: right adjustment part; 1013: chest belt; 1014: back belt; 1015: upper and lower adjustment part; 1016: positioning reference mark; 1017: upper adjustment belt; 1018: lower adjustment belt; 102: leg belt; 1021: leg adjustment belt; 103: hand belt; 1031: hand adjustment belt ; 200: ECG module 201: limb lead; 2011: limb electrode; 202: chest lead; 2021: chest electrode; 2022: ECG electrode shell; 2023: conductive liquid storage chamber; 2024: capillary pores; 2025: ECG electrode sheet; 203: connection patch; 300: defibrillator module; 301: first defibrillator electrode; 3010: electrode shell; 3011: inner cavity; 3012: outer cavity; 3013: attachment ring; 3014: outer ring; 3015: inner ring; 3016: vacuum ring; 3017: micropore; 3018: attachment liquid storage cavity; 3019: attachment liquid flow channel; 3020: control valve; 3021: conductive liquid flow channel; 3022: inner cavity inflation channel; 3023: inner cavity inflation valve; 3024: outer cavity inflation channel; 3025: outer cavity inflation valve; 3026: gas pump; 3027: outer cavity inflation channel; 3028: outer cavity inflation valve; 3029: outer cavity inflation channel; 3030: outer cavity inflation valve; 3031: outer cavity inflation channel; 3032: outer cavity inflation channel; 3033: outer cavity inflation channel; 3034: outer cavity inflation channel; 3035: outer cavity inflation valve; 3036: gas pump; 3037: outer cavity inflation channel; 3038: outer cavity inflation channel; 3039: outer cavity inflation channel; 3040: outer cavity inflation channel; 3041: outer cavity inflation channel; 3042: outer cavity inflation channel; 3043: outer cavity inflation channel; 3044: outer cavity inflation channel; 3045: outer cavity inflation valve; 3046: gas pump; 3047: outer cavity inflation channel; 3048: outer cavity inflation channel; 3049: outer cavity inflation channel; 3050: outer cavity inflation channel; 3051: outer cavity inflation channel; 3052: outer cavity inflation channel; 3053: outer cavity inflation channel; 3054: outer cavity inflation channel; 3055: outer cavity inflation channel; 3056: outer cavity inflation channel; 3057: outer cavity inflation channel; 3058: outer cavity inflation channel; 3059: outer cavity inflation channel; 3060: outer cavity inflation channel 027: hydrophobic membrane; 3028: vacuum pump; 3029: electrode sheet; 302: second defibrillation electrode; 303: third defibrillation electrode; 400: control module; 401: computing unit; 402: storage unit; 403: communication unit; 404: positioning unit; 405: energy management unit; 500: monitoring module; 501: smart watch; 502: monitoring terminal; 503: cloud server. DETAILED DESCRIPTION

[0062] The present invention is described in detail below with reference to the accompanying drawings.

[0063] Example 1

[0064] like Figure 1As shown, the present application provides a wearable intelligent defibrillator monitoring device, including a wearable WCD band 100, which is used to limit the ECG detection and defibrillator equipment to a specific position of the patient and is detachably connected to the patient in a manner that can cover the ECG monitoring area and the defibrillator area, wherein the WCD band 100 is provided with a chest band 1013 and a back band 1014 in a manner that covers the chest area and the back area of ​​the patient at a certain height centered on the heart contour line through a central band 101 arranged on the upper body of the patient; the WCD band 100 also includes a leg band 102 and a hand band 103 respectively arranged on the patient's legs and hands.

[0065] The device includes an ECG module 200 for ECG detection. The ECG module 200 is provided with limb leads 201 and chest leads 202 in a manner that can respectively detect the limbs and chest of the patient. The chest leads 202 measure and monitor the ECG data of the patient based on the chest electrodes 2021 arranged on the side of the chest cuff 1013 close to the patient's skin; the limb leads 201 form an ECG detection system based on the limb electrodes 2011 arranged on the side of the leg cuff 102 and the hand cuff 103 close to the patient's skin to obtain more comprehensive and accurate ECG data. The limb electrodes 2011 and the chest electrodes 2021 are detachably connected to the leg cuff 102 / hand cuff 103 and the chest cuff 1013 through the connecting patch 203, so that the arrangement points of the electrodes can be adjusted as needed.

[0066] The device includes a defibrillation module 300 for performing defibrillation treatment on a patient, wherein the defibrillation module 300 is provided with a first defibrillation electrode 301, a second defibrillation electrode 302 and a third defibrillation electrode 303 in a manner capable of forming different defibrillation treatment modes, wherein Figure 1 and Figure 2 As shown, the first defibrillation electrode 301 is limited to the heart area on the side of the chest band 1013 close to the patient's skin based on the chest band 1013; the second defibrillation electrode 302 is set in the back area at a height substantially equal to the heart and is limited by the back band 1014; the third defibrillation electrode 303 is set in the left armpit at a position substantially equal to the heart and is limited by the chest band 1013.

[0067] Preferably, if Figure 3As shown, the central cuff 101 arranged in the patient's heart-level area is provided with a left adjustment portion 1011 and a right adjustment portion 1012 at the position where the chest cuff 1013 and the back cuff 1014 contact each other, and the left adjustment portion 1011 is arranged in the patient's left armpit area in a manner that the chest cuff 1013 and the back cuff 1014 can be laterally adjusted respectively; the right adjustment portion 1012 is arranged in the patient's right armpit area in a manner that the chest cuff 1013 and the back cuff 1014 can be laterally adjusted; so that the ECG module 200 and the defibrillator module 300 can adjust their positions arranged in the chest cuff 1013 and the back cuff 1014 as needed, and the chest cuff 1013 and the back cuff 1014 are limited to the area at the same height as the patient's heart by means of the left adjustment portion 1011 and the right adjustment portion 1012 for laterally adjusting the chest cuff 1013 and the back cuff 1014.

[0068] Preferably, the center ring band 101 also includes an upper and lower adjustment portion 1015 for adjusting the height of the center ring band 101 on the patient's body. The upper and lower adjustment portion 1015 is arranged with an upper adjustment belt 1017 and a lower adjustment belt 1018 in a manner that can respectively change the degree of contact tightness between the upper edge and the lower edge of the center ring band 101 and the patient's body, so that the upper adjustment belt 1017 and the lower adjustment belt 1018 can change the enclosing size of the upper edge and the lower edge of the center ring band 101 based on the adjustment effect on the center ring band 101 and cooperate with the left adjustment portion 1011 and the right adjustment portion 1012 to meet the tightening needs of the center ring band 101 when moving up and down on the patient's body.

[0069] Preferably, at least one of the left adjustment portion 1011, the right adjustment portion 1012, the upper adjustment strap 1017, the lower adjustment strap 1018, the hand adjustment strap 1031 and the leg adjustment strap 1021 is provided with a positioning reference mark 1016, and the positioning reference mark 1016 is arranged in a manner that can record the adjustment degree and position according to the set scale or regularly changing marks, so that the positioning reference mark 1016 can assist in the wearing and tightening of the WCD ring belt 100.

[0070] Preferably, when the central ring belt 101 is first arranged on the patient's body, the ECG module 200 and the defibrillator module 300 are not set first, and the central ring belt 101 cooperates with the upper adjustment belt 1017 and the lower adjustment belt 1018 to respectively limit the chest ring belt 1013 and the back ring belt 1014 to positions substantially consistent with the patient's heart height through the left adjustment part 1011 and the right adjustment part 1012; when the central ring belt 101 basically covers the position where the ECG module 200 and the defibrillator module 300 are arranged on the patient and the tightening force of the central ring belt 101 on the patient's body is appropriate, positioning marks are set on the surface of the central ring belt 101 to record the ECG electrodes and the defibrillator electrodes around the chest cavity. The arrangement position of the center belt 101 is recorded, and the data of the positioning reference marks 1016 of the left adjustment part 1011, the right adjustment part 1012, the upper adjustment belt 1017 and the lower adjustment belt 1018 are recorded; the center belt 101 is untied, and the ECG electrodes and the defibrillation electrodes are arranged on the side of the center belt 101 in contact with the patient's skin based on the positioning marks, and the ECG electrodes and the defibrillation electrodes can be connected to the center belt 101 based on the connection patch 203; the center belt 101 arranged with the ECG electrodes and the defibrillation electrodes is reconnected to the patient, so that the arrangement position of the ECG module 200 and the defibrillation module 300 in the center module is accurate and adjustable, and can also be adjusted to adapt to the wearing of different patients.

[0071] Preferably, if Figure 4 As shown, the leg band 102 and the hand band 103 for limiting the limb electrode 2011 are respectively provided with a leg adjustment band 1021 and a hand adjustment band 1031 in a manner that can be stretched or contracted, so that the leg band 102 and the hand band 103 can change the encirclement size based on the leg adjustment band 1021 and the hand adjustment band 1031, so that the leg band 102 and the hand band 103 can adapt to different limb positions of different sizes or limbs of different patients. For example, the leg adjustment band 1021 and the hand adjustment band 1031 can be configured as an elastic band with a Velcro male part passing through the buckle and reversely overlapped with the Velcro female part set on the adjustment band or the ring band, or can be configured as an adjustment band with a pattern on one side passing through the buckle, and when the adjustment band tightens the ring band, the switch of the buckle cooperates with the pattern of the adjustment band to limit.

[0072] Preferably, when the device performs ECG detection and defibrillation treatment on a patient, the ECG module 200 and the defibrillation module 300 need to establish a reliable electrical connection with the patient's body. Figure 6As shown, at least one of the first defibrillation electrode 301, the second defibrillation electrode 302 and the third defibrillation electrode 303 includes an electrode shell 3010 for accommodating electrode components and forming a protective shell, so that the electrode shell 3010 can resist external pressure and transmit the pressure to the attachment ring 3013 of the electrode shell 3010 in contact with the skin; the electrode shell 3010 is provided with a layered inner cavity 3011 and an outer cavity 3012 in the internal space in a manner that the conductive liquid can flow back and forth, wherein the inner cavity 3011 is arranged on the side of the outer cavity 3012 close to the patient's skin in a manner that the internal space of the inner cavity 3011 directly contacts the skin, and the outer cavity 3012 is connected to the inner cavity 3011 in a manner that it can accommodate the conductive liquid and discharge the conductive liquid into the inner cavity 3011 through at least one conductive liquid flow channel 3021 based on air pressure. For example, the volume of the outer cavity 3012 can be greater than the volume of the inner cavity 3011, so that part of the conductive liquid in the outer cavity 3012 can fill the inner cavity 3011.

[0073] Preferably, when the first defibrillation electrode 301 is limited to the patient's skin surface based on the effect of the central ring band 101, the electrode sheet 3029 of the first defibrillation electrode 301 arranged in the inner cavity 3011 fits the patient's skin. An attachment ring 3013 for keeping the electrode shell 3010 in close contact with the skin is provided at the edge of the inner cavity 3011 in contact with the skin. The attachment ring 3013 is configured as a double-layer ring structure in such a way that an inner ring 3015 and an outer ring 3014 arranged at different radial distances from the center of the inner cavity 3011 can surround and form an internal hollow vacuum ring 3016.

[0074] Preferably, a plurality of micropores 3017 through which the attachment liquid can penetrate are arranged on the surface of the inner ring 3015 and the outer ring 3014 in contact with the skin, and the micropores 3017 are connected to the attachment liquid storage chamber 3018 based on the attachment liquid flow channel 3019, so that the attachment liquid can be transported to the micropores 3017 by the capillary action of the attachment liquid flow channel 3019 and infiltrate the surface of the inner ring 3015 and the outer ring 3014 in contact with the skin, so that the inner ring 3015 and the outer ring 3014 can closely fit the skin based on the attachment liquid and form a vacuum ring 3016 isolated from the air, wherein the vacuum ring 3016 is connected to the attachment liquid flow channel 3019 and the attachment liquid storage chamber 3018. 016 In the case where an independent space is formed by the inner ring 3015 and the outer ring 3014, the vacuum pump 3028 can configure the vacuum ring 3016 with a closed space having a certain vacuum degree by evacuating the inside of the vacuum ring 3016, so that the electrode shell 3010 can be further attached to the patient's skin surface based on the pressure difference between the atmospheric pressure and the vacuum ring 3016. The combined action of the inner ring 3015, the outer ring 3014 and the vacuum ring 3016 will also ensure the tightness of the inner cavity 3011 against the skin, so that the inner cavity 3011 can accommodate the conductive liquid without leakage.

[0075] Preferably, the attachment ring 3013 and vacuum ring 3016 made of a material with both flexibility and toughness can be well attached to the patient's skin surface, and can still maintain good adhesion even when the attachment point is uneven. In the inner cavity 3011, based on the attachment ring 3013 and vacuum ring 3016 and the skin, the gas pump 3026 applies gas to the outer cavity 3012 containing the conductive liquid through the outer cavity inflation valve 3025 and the outer cavity inflation channel 3024, so that the conductive liquid is transferred to the inner cavity 3011 through the conductive liquid flow channel 3021 and the control valve 3020 under the action of gas compression and fills the inner cavity 3011, and the air in the inner cavity 3011 is discharged from the inner cavity 3011 through the inner cavity inflation channel 3022 and the inner cavity inflation valve 3023. The electrode sheet 3029 arranged in the inner cavity 3011 can establish an effective electrical connection with the skin based on the conductive liquid filling the inner cavity 3011, wherein the control valve 3020, the outer cavity inflation valve 3025 and the inner cavity inflation valve 3023 are opened / closed when the pressure difference on both sides is greater than / less than the pressure difference threshold, and the outer cavity inflation channel 3024 and the inner cavity inflation channel 3022 are respectively provided with at least one hydrophobic membrane 3027 at the connection between the outer cavity 3012 and the inner cavity 3011, so that air can pass through but the conductive liquid cannot.

[0076] Preferably, after the defibrillator module 300 finishes the electric shock, the gas pump 3026 discharges air into the inner cavity 3011 through the inner cavity inflation channel 3022 and the inner cavity inflation valve 3023, so that the conductive liquid in the inner cavity 3011 is discharged back to the outer cavity 3012 through the conductive liquid flow channel 3021 and the control valve 3020 under the pressure of the air, and the air in the outer cavity 3012 is discharged from the outer cavity 3012 through the outer cavity inflation channel 3024 and the outer cavity inflation valve 3025, so that the defibrillator module 300 can keep the conductive liquid in the outer cavity 3012 when not working to enhance the comfort of long-term wearing.

[0077] Preferably, the vacuum ring 3016 is provided with a first pressure sensor for obtaining the vacuum degree of the vacuum ring 3016. When the vacuum degree detected by the first pressure sensor is less than the vacuum degree threshold, the vacuum pump 3028 is automatically started to reduce the pressure inside the vacuum ring 3016; the inner cavity 3011 and the outer cavity 3012 are provided with a second pressure sensor and a third pressure sensor. When the inflation pressure of the inner cavity 3011 or the outer cavity 3012 reaches the first pressure threshold, the gas pump 3026 stops working, and the pressure difference on both sides of the first inflation valve, the control valve 3020 and the second inflation valve gradually decreases to below the pressure difference threshold, and the first inflation valve, the control valve 3020 and the second inflation valve are closed.

[0078] Preferably, the way in which the ECG module 200 establishes electrical connection with the skin can refer to the structure of the defibrillator module 300 and simplify the setting. Figure 5As shown, at least one of the limb electrode 2011 and the chest electrode 2021 is provided with an ECG electrode shell 2022 for accommodating an ECG electrode sheet 2025, and a conductive liquid storage chamber 2023 for accommodating a conductive liquid is provided inside the ECG electrode shell 2022. The conductive liquid storage chamber 2023 transports the conductive liquid to the position where the ECG electrode sheet 2025 contacts the skin through the capillary action of the capillary pores 2024 connected to the conductive liquid storage chamber 2023, so that the limb electrode 2011 / chest electrode 2021 that is in contact with the skin under the limitation of the leg band 102 / hand band 103 / center band 101 establishes an electrical connection with the skin.

[0079] Preferably, the limb electrodes 2011 and the chest electrodes 2021 can be arranged in a twelve-lead arrangement, that is, the electrocardiogram and lead wires are divided into five colors: red, yellow, green, black, and white. The white wires are divided into C1, C2, C3, C4, C5, and C6, a total of 10 wires; the red wire is connected to the right upper limb, the yellow wire is connected to the left upper limb, the green wire is connected to the left lower limb, and the black wire is connected to the right lower limb. Each lead of the white lead wire is connected to the corresponding lead on the chest. The specific placement positions are as follows:

[0080] Limb lead 201: Limb lead I is connected to the negative pole at the right upper limb, and the positive pole at the left upper limb. Limb lead II is connected to the negative pole at the right upper limb, and the positive pole at the left lower limb. Limb lead III is connected to the negative pole at the left upper limb, and the positive pole at the left lower limb. Pressurized unipolar limb lead aVR is connected to the positive pole at the right upper limb, and the negative pole is connected to the left upper limb and the left lower limb. Pressurized unipolar limb lead aVL is connected to the positive pole at the left upper limb, and the negative pole is connected to the right upper limb and the left lower limb. Pressurized unipolar limb lead aVF is connected to the positive pole at the left lower limb, and the negative pole is connected to the left upper limb and the right upper limb;

[0081] Chest lead 202: V1 is located at the 4th intercostal space on the right edge of the sternum; V2 is located at the 4th intercostal space on the left edge of the sternum, opposite to V1; V3 is at the midpoint of the line connecting V2 and V4; V4 is located at the midclavicular line at the 5th left intercostal space; V5 is located at the same level as V4 on the left anterior axillary line; V6 is located at the same level as V4 and V5 on the left mid-axillary line; V7 is located at the same level as V4 and V5 on the left posterior axillary line; V8 is located at the same level as V4, V5, V6, and V7 at the left inferior angle of the scapula; V9 is located next to the left clavicle and at the same level as V4, V5, and V6; V3R, V4R, and V5R are arranged on the right side of the chest at the corresponding positions of V3, V4, and V5.

[0082] For example, the lead electrodes of the present application can be made of silver-silver chloride, which can detect and promptly discover heart rhythm disorders and / or bradycardia, tachycardia, etc., but the electrode plate should be placed in a position that meets the following conditions: the P wave is clear and obvious (such as sinus rhythm); the QRS wave amplitude must be clear and reach a certain amplitude to trigger heart rate counting and alarm; it does not interfere with rescue operations (such as defibrillation, etc.), and can be used for electrical cardioversion treatment in the following processes: Cardiopulmonary resuscitation: ECG monitoring during cardiopulmonary resuscitation helps analyze the cause of cardiac arrest and guide treatment (such as defibrillation, etc.); monitoring of surface electrocardiograms can promptly detect heart rhythm disorders; after successful resuscitation, changes in heart rhythm and heart rate should be monitored until they stabilize; Patients at high risk of heart rhythm disorders: Many diseases can cause fatal heart rhythm disorders during the course of the disease. ECG monitoring is an important method for detecting serious arrhythmias, preventing sudden death and guiding treatment; ECG monitoring for critical illnesses: acute myocardial infarction, myocarditis, cardiomyopathy, heart failure, cardiogenic shock, severe infection, preexcitation syndrome and after cardiac surgery, etc. ECG monitoring should also be performed on patients who have received certain drugs that are myocardially toxic or affect the cardiac conduction system. In addition, various critical illnesses are accompanied by hypoxia, electrolyte and acid-base imbalance (especially potassium, sodium, calcium, magnesium), and multi-system organ failure; certain diagnostic and therapeutic operations: such as endotracheal intubation, cardiac catheterization, and pericardial puncture, can cause arrhythmias and lead to sudden death, and ECG monitoring is necessary; detection and monitoring processes outside medical institutions, etc.

[0083] Preferably, if Figure 7 As shown, the device includes a control module 400 that analyzes detection data of the ECG module 200 and controls the defibrillation module 300 to perform defibrillation treatment. The control module 400 establishes an electrical connection with the ECG module 200 in a manner that can respectively obtain detection data of the limb electrodes 2011 and the chest electrodes 2021 of the ECG module 200; the control module 400 establishes an electrical connection in a manner that can respectively send electric shock signals to the first defibrillation electrode 301, the second defibrillation electrode 302, and the third defibrillation electrode 303 of the defibrillation module 300 according to the defibrillation strategy.

[0084] Preferably, the control module 400 includes a storage unit 402 for recording historical ECG data. The storage unit 402 is electrically connected to the computing unit 401, so that the computing unit 401 can form an ECG based on the real-time detection data of the ECG module 200 and the historical ECG data of the storage unit and send it to the storage unit 402 for preservation. The storage unit 402 and the computing unit 401 are both electrically connected to the communication unit 403, so that the communication unit 403 can transmit the data transmitted by the storage unit 402 or the computing unit 401 to the monitoring module 500 based on wireless communication or wired means. The monitoring module 500 includes at least one or more of a smart watch 501 worn on the patient's hand, a monitoring terminal 502 carried by a guardian, and a cloud server 503.

[0085] Preferably, the control module 400 includes a positioning unit 404 for determining the real-time position of the patient and an energy management unit 405 for managing the electrical energy required for defibrillation treatment. The energy management unit 405 can output an electric shock signal of a certain energy to the defibrillation module 300300 according to different defibrillation strategies.

[0086] Preferably, the calculation unit 401 establishes the patient's electrocardiogram based on the real-time detection data of the electrocardiogram module 200 and the historical electrocardiogram data of the storage unit 402, and determines the current electrocardiogram state including the first state to the eighth state according to the electrocardiogram characteristics, and the control module 400 formulates a defibrillation strategy including at least the first strategy to the eighth strategy according to the first state to the eighth state; wherein the first state is a normal sinus rhythm state; the second state is a preparatory state with a slight deviation from sinus rhythm; the third state is a ventricular fibrillation state; the fourth state is a ventricular tachycardia state; the fifth state is an atrial fibrillation state; the sixth state is an atrial flutter state; the seventh state is a supraventricular tachycardia state; and the eighth state is a state in which sinus rhythm has not been fully restored after defibrillation treatment.

[0087] Preferably, when the computing unit 401 continuously acquires the current ECG data and the historical ECG data and performs continuous analysis, different defibrillation strategies are respectively adopted to perform electric cardioversion treatment on the patient when the patient is currently in different ECG states, wherein the first strategy may be to maintain the detection state, and the control module 400 does not send an electric shock signal to the defibrillator module 300; the second strategy may be that the computing unit 401 reviews the current ECG in the second state, and if the review result does not change, the computing unit 401 continues to maintain the detection state; if the review result changes, the control module 400 operates according to the updated defibrillation strategy; the third strategy may be that the control module 400 controls the energy management unit 405 to send an electric shock signal with an energy of 250-300J to the defibrillator module 300, and the electric shock type is asynchronous cardioversion; the fourth strategy may be that the control module 400 controls the energy management unit 405 to send an electric shock signal with an energy of 250-300J to the defibrillator module 300, and the electric shock type is asynchronous cardioversion; The defibrillator module 300 sends an electric shock signal with an energy of 150-200J, and the shock type is synchronized cardioversion; the fifth strategy may be that the control module 400 controls the energy management unit 405 to send an electric shock signal with an energy of 150-200J to the defibrillator module 300, and the shock type is synchronized cardioversion; the sixth strategy may be that the control module 400 controls the energy management unit 405 to send an electric shock signal with an energy of 80-100J to the defibrillator module 300, and the shock type is synchronized cardioversion; the seventh strategy may be that the control module 400 controls the energy management unit 405 to send an electric shock signal with an energy of 100J to the defibrillator module 300, and the shock type is synchronized cardioversion; the eighth strategy may be that the calculation unit 401 reviews the electrocardiogram, and if the review result does not change, the calculation unit 401 continues to maintain the detection state; if the review result changes, the control module 400 operates according to the updated defibrillation strategy.

[0088] Most cardiac defibrillators use the RLC damping discharge method. The voltage converter converts the DC low voltage into a pulse high voltage, which is then rectified by the high voltage to charge the energy storage capacitor C, so that the capacitor can obtain a certain amount of energy storage. During defibrillation treatment, the high-voltage relay K is controlled to operate, and the energy storage capacitor C, the inductor L and the human body (load) are connected in series to form an RLC series resonance. This refers to the maximum energy value stored at both ends of the energy storage capacitor before the defibrillation shock, and the unit is expressed in joules (J). Experiments have shown that the safe dose of electric shock, that is, the maximum energy storage value, should not exceed 400J. The time required for the energy storage capacitor to charge to the maximum energy storage value is called the maximum energy storage time. The smaller this parameter is, the better, because the shorter the energy storage time, the less preparation time is required for rescue and treatment. However, due to the limitation of the internal resistance of the power supply, this time cannot be reduced indefinitely. At present, the maximum energy storage time of most defibrillators is within the range of (10-15)s. This refers to the highest voltage value on the load when the defibrillator releases energy to a certain load at the maximum energy storage value. In order to ensure safety and prevent patients from being exposed to excessive voltage during defibrillation shocks, the International Electrotechnical Commission stipulates that when the defibrillator releases the maximum energy storage value to the resistive load, the maximum voltage value on the load should not exceed 5000V.

[0089] Preferably, there are two arrangements of the defibrillator module 300. The first is called the anterior-posterior position, that is, one defibrillator electrode plate is placed in the subscapular region of the back; the other defibrillator electrode plate is placed at the level of the 3rd to 4th intercostal space on the left edge of the sternum, which is suitable for energy saving, less potential complications and selective cardioversion. The second is called the anterior-left position, in which the first defibrillator electrode 301 plate is placed at the 2nd to 3rd intercostal space on the right edge of the sternum (the bottom of the heart), and the second defibrillator electrode 302 is placed at the 5th intercostal space (the apex of the heart) in the left anterior axillary line, which is suitable for emergency electric shock defibrillation.

[0090] Preferably, the first defibrillation electrode 301 and the second defibrillation electrode 302 of the defibrillation module 300 form an anterior-posterior position, and the first defibrillation electrode 301 and the third defibrillation electrode 303 form an anterior-left position. When the transition time of the ECG state from the first state to the third state to the seventh state is greater than or equal to the first time threshold, the defibrillation module 300 preferentially adopts the anterior-posterior position for electric shock defibrillation; when the transition time from the first state to the third state to the seventh state is less than the first time threshold, the defibrillation module 300 preferentially adopts the anterior-left position for electric shock defibrillation.

[0091] Preferably, when the calculation unit 401 determines that the ECG state changes from the first state to the second state and the change time is greater than or equal to the second time threshold, the control module 400 controls the defibrillator module 300 to enter the pre-working state with the first power, the vacuum pump 3028 and the gas pump 3026 start to operate, and the conductive liquid enters the inner cavity 3011, so that an electrical connection is established between the electrode sheet 3029 and the skin; when the calculation unit 401 determines that the ECG state changes from the first state to the second state and the change time is less than the second time threshold, the control module 400 controls the defibrillator module 300 to enter the pre-working state with the second power, the vacuum pump 3028 and the gas pump 3026 start to operate, and the conductive liquid enters the inner cavity 3011 at an accelerated speed, so that a faster electrical connection is established between the electrode sheet 3029 and the skin.

[0092] Preferably, when the ECG state is in the eighth state, the control module 400 controls the defibrillator module 300 to maintain a pre-working state of establishing an electrical connection; when the time for the ECG state to recover from the second state to the eighth state to the first state is greater than a third time threshold, the control module 400 controls the defibrillator module 300 to discharge the conductive liquid in the inner cavity 3011 to the outer cavity 3012, and the defibrillator module 300 ends the pre-working state.

[0093] Preferably, when the computing unit 401 of the control module 400 generates an electrocardiogram based on the current electrocardiogram data and the historical electrocardiogram and performs continuous analysis, the control module 400 transmits the current electrocardiogram and the electrocardiogram to the cloud server 503 of the monitoring module 500 through the communication module for backup storage; when the computing module determines that the current electrocardiogram state is the third to seventh state, the control module 400 simultaneously sends the current positioning data, electrocardiogram data, electrocardiogram, electrocardiogram state and defibrillation strategy information to the remote server, smart watch 501 and monitoring terminal 502 of the monitoring module 500, and the smart watch 501 sends a warning signal to the patient in the form of vibration or light, reminding the patient to avoid exercise as much as possible or end exercise to maintain peace and stability; the monitoring terminal 502 can remind the guardian or medical staff to pay attention to the patient's condition and be ready to intervene to provide help.

[0094] Preferably, the smart watch 501 and the monitoring terminal 502 can call the remote server at any time to view the current ECG data, ECG and historical ECG data; when the calculation module determines that the time when the ECG state is in the third state to the seventh state is greater than the fourth time threshold, the control module 400 sends an alarm signal to the smart watch 501 and the monitoring terminal 502 based on the communication unit 403 and notifies medical staff to intervene.

[0095] Example 2

[0096] Since it is worn on the patient, it is faster than using an external AED device (automated external defibrillator), but it also requires more thorough safety considerations and more complete safety settings.

[0097] Although the voltage used for defibrillation may not be enough to threaten a person's basic life, electric shock can still have a negative impact on people. For example, the muscle contraction caused by electric shock can make people feel uncomfortable. For patients with low resistance, the elderly, and children, even low-amplitude electric shocks may still pose a great hidden danger. Compared with conventional external AED devices, it is often outsiders who discover that the patient has obvious symptoms of arrhythmia (for example, he has fallen to the ground and is unable to get up, covering his chest and showing pain, etc.). At this time, it is usually no problem and urgently necessary to use CPR cardiopulmonary resuscitation or external AED on the patient. However, for wearable defibrillator devices, because they are extremely close to the user side, they can receive the user's physiological information relatively quickly. In theory, they can discover the user's arrhythmia before the outside world (which can refer to external personnel, external detection equipment, etc.) and immediately give electric shock defibrillation. However, it is also easier to misjudge due to overly rapid processing and judgment, and give unnecessary electric shocks to the user. When a user shows some signs of arrhythmia, it does not necessarily mean that the condition is serious enough to require defibrillation. On the contrary, improper electrodes can easily cause unexpected heart arrhythmias, and equipment errors can cause physical damage or even serious injuries to the user. The issue of how to determine responsibility is also very complicated. Therefore, how to safely handle the relationship between the wearable defibrillator and the user is a very important task.

[0098] Based on this, the present embodiment provides the following scheme: based on the ECG detection result obtained by the ECG module 200, the defibrillator module 300 is controlled to be in three states: shutdown, stagnant and action. The shutdown state means that the defibrillator module 300 is completely shut down, at least without any actual action; the action state means that the defibrillator module 300 is in and performs electric shock defibrillation on the user's body; the stagnant state means that based on the omen information provided by the ECG detection unit, the defibrillator module 300 performs at least one defibrillation-related sub-step but not all defibrillation-related steps. The defibrillation-related sub-steps at least include pre-energizing the defibrillator electrode to a predetermined voltage, ventilation to increase the pressure in part of the cavity, opening or closing part of the control valve, etc.

[0099] In this solution, the viscous state as a neutral position between action and non-action provides a better guarantee for the safe use of wearable defibrillator equipment. Specifically, for different ECG detection results given by the ECG module 200, the defibrillator module 300 switches to the corresponding working state. When the ECG detection results are in the first result in several preset cycles, the defibrillator module 300 switches to or remains in the shutdown state; the first result can be that the ECG state is in a normal sinus rhythm state, and the several preset cycles can be set to 3 adjustable preset cycles. When the patient's ECG state is in a stable normal state or recovers to a normal state for a certain time limit, the defibrillator module 300 is in the shutdown state.

[0100] When the ECG detection result is in the second result, the ECG state changes from the first state to the second state, the patient's ECG state deviates slightly from normal, but has not yet developed to the stage where immediate defibrillation is required, or the ECG state changes from the third to seventh states to the eighth state, the patient has received defibrillation treatment but has not yet fully recovered to normal sinus rhythm, then the defibrillation module 300 switches or maintains a viscous state.

[0101] In response to the different change times from the first state to the second state, the sticky state is also divided into at least three sub-modes, the first, second and third sticky modes. In the first sticky mode, the defibrillator module 300 generates mechanical action but not electrical action, in the second sticky mode, the defibrillator module 300 generates electrical action but not mechanical action, and in the third sticky mode, both the mechanical action and the electrical action are in a standby state but not in an action state. When the ECG detection result is the second result, if the change time from the first state to the second state is greater than the first threshold, the defibrillator module 300 enters the first sticky mode; if the change time from the first state to the second state is greater than the second threshold and not greater than the first threshold, the defibrillator module 300 enters the second sticky mode; when the change time from the first state to the second state is not greater than the third threshold, the defibrillator module 300 enters the third sticky mode; when the ECG state is in the eighth state, the defibrillator module 300 maintains the third sticky mode.

[0102] Mechanical action may refer to the pressure generated by inflation to squeeze out the conductive liquid so that the electrode and the user's skin establish a conductive channel; electrical action may refer to the voltage required for defibrillation generated by the energy management unit. Only when both electrical action and mechanical action are implemented can the user's electric shock defibrillation be completed. The standby state may refer to that the energy management unit or the defibrillator module 300 has made corresponding preparations before the actual action. These preparations can be in the signal range or in the action range, such as the power-on signal communication of the electrode or the heat engine of the inflation unit. Based on the above settings, the viscous state fills the gray area between the action and non-action of the defibrillator module 300 very well, and can better prevent the defibrillator module 300 from misjudging and causing the user to suffer unexpected electric shocks. At the same time, it will not delay the user's defibrillation when needed, and can accurately select a variety of viscous state modes based on the judgment of the patient's physical condition, and reasonably arrange the sequence of relatively slow mechanical actions and relatively fast electrical actions in various states. While reducing the possibility of the user's body surface being contaminated by the untimely release of conductive fluid, sufficient standby voltage is always prepared to prevent the user from actually experiencing the risk of arrhythmia.

[0103] It should be noted that the above specific embodiments are exemplary, and those skilled in the art can come up with various solutions inspired by the disclosure of the present invention, and these solutions also belong to the disclosure scope of the present invention and fall within the protection scope of the present invention. Those skilled in the art should understand that the present invention description and its drawings are illustrative and do not constitute a limitation of the claims. The protection scope of the present invention is defined by the claims and their equivalents.

Claims

1. A wearable intelligent defibrillator monitoring device, characterized in that: The device comprises: A WCD loop (100) for limiting an ECG detection and defibrillation device to a specific position of a patient, the WCD loop (100) being detachably connected to the patient in a manner capable of covering an ECG monitoring area and a defibrillation area; An electrocardiogram module (200), wherein the electrocardiogram module (200) is provided with limb leads (201) and chest leads (202) in a manner capable of performing electrocardiogram detection on a patient's limbs and chest respectively; A defibrillation module (300) for providing electrical cardioversion therapy, the defibrillation module (300) being arranged with a plurality of defibrillation electrodes in a manner that can be set to an anteroposterior or anterior left defibrillation therapy mode; A control module (400) for analyzing the detection data of the electrocardiogram module (200) and controlling the defibrillation module (300) to perform defibrillation treatment; The defibrillation electrode establishes or terminates electrical connection with the patient's skin by means of a conductive liquid flowing back and forth between the inner cavity (3011) and the outer cavity (3012); The defibrillation module (300) is provided with a first defibrillation electrode (301), a second defibrillation electrode (302) and a third defibrillation electrode (303) in a manner capable of forming different defibrillation treatment modes, wherein at least one of the first defibrillation electrode (301), the second defibrillation electrode (302) and the third defibrillation electrode (303) comprises an electrode shell (3010) for accommodating electrode components and forming a protective shell, so that the electrode shell (3010) can resist external pressure and transmit pressure to an attachment ring (3013) in contact with the skin of the electrode shell (3010) based on a shell-like structure with a cavity; The electrode shell (3010) is provided with the inner cavity (3011) and the outer cavity (3012) arranged in layers in the internal space in such a manner that the conductive liquid can flow back and forth, wherein the inner cavity (3011) is arranged on the side of the outer cavity (3012) close to the patient's skin in such a manner that the internal space of the inner cavity (3011) is in direct contact with the skin, and the outer cavity (3012) is connected to the inner cavity (3011) in such a manner that it can accommodate the conductive liquid and discharge the conductive liquid into the inner cavity (3011) through at least one conductive liquid flow channel (3021) based on air pressure; The edge of the inner cavity (3011) contacting the skin is provided with the attachment ring (3013) for keeping the electrode shell (3010) in close contact with the skin, and the attachment ring (3013) is configured as a double-layered ring structure in such a way that an inner ring (3015) and an outer ring (3014) arranged at different radial distances from the center of the inner cavity can surround and form an internally hollow vacuum ring (3016); A plurality of micropores (3017) capable of permeating adhesion liquid are provided on the surfaces of the inner ring (3015) and the outer ring (3014) in contact with the skin. The micropores (3017) are connected to the adhesion liquid storage chamber (3018) based on the adhesion liquid flow channel (3019), so that the adhesion liquid is transported to the micropores (3017) based on the capillary action of the adhesion liquid flow channel (3019) and infiltrates the surfaces of the inner ring (3015) and the outer ring (3014) in contact with the skin.

2. The device according to claim 1, characterized in that Based on the adhesion of the attachment ring (3013) and the vacuum ring (3016) to the skin, the gas pump (3026) applies gas to the outer cavity (3012) containing the conductive liquid through the outer cavity inflation valve (3025) and the outer cavity inflation channel (3024), so that the conductive liquid is transferred to the inner cavity (3011) through the conductive liquid flow channel (3021) and the control valve (3020) under the action of gas compression and fills the inner cavity (3011), and the air in the inner cavity (3011) is discharged from the inner cavity (3011) through the inner cavity inflation channel (3022) and the inner cavity inflation valve (3023).

3. The device according to claim 1, characterized in that At least one of the limb electrodes (2011) and the chest electrodes (2021) is provided with an ECG electrode shell (2022) for accommodating an ECG electrode sheet (2025); a conductive liquid storage chamber (2023) for accommodating a conductive liquid is provided inside the ECG electrode shell (2022); the conductive liquid storage chamber (2023) transports the conductive liquid to the position where the ECG electrode sheet (2025) contacts the skin through the capillary action of the capillary pores (2024) connected to the conductive liquid storage chamber (2023).

4. The device according to claim 1, characterized in that A central ring belt (101) arranged at a height equal to that of the patient's heart is provided with a left adjustment portion (1011) and a right adjustment portion (1012) at a position where a chest ring belt (1013) and a back ring belt (1014) contact each other. The central ring belt (101) further comprises an upper and lower adjustment portion (1015) for adjusting the height at which the central ring belt (101) is arranged on the patient's body. The upper and lower adjustment portions (1015) are provided with an upper adjustment belt (1017) and a lower adjustment belt (1018) in a manner capable of respectively changing the degree of contact between the upper edge and the lower edge of the central ring belt (101) and the patient's body.

Citation Information

Patent Citations

  • wearable devices

    CN108289611B

  • Pressure-resistant conductive fluid containment

    CN108290035B

  • Remote electrocardiograph monitoring and health information management system and method

    CN113616927A

  • Wearing formula intelligence defibrillator

    CN204815373U

  • Twelve-lead wearable electrocardiogram monitoring garment

    CN210541542U